Literature DB >> 20066536

Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection.

Gerd Heusch, Kerstin Boengler, Rainer Schulz.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20066536     DOI： 10.1007/s00395-009-0080-9

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN： 0300-8428            Impact factor:   17.165


× No keyword cloud information.
  96 in total

1.  Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy.

Authors:  Jingyuan Li; Soban Umar; Andrea Iorga; Ji-Youn Youn; Yibin Wang; Vera Regitz-Zagrosek; Hua Cai; Mansoureh Eghbali
Journal:  Basic Res Cardiol       Date:  2012-05-31       Impact factor: 17.165

2.  Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.

Authors:  J P Sarkey; M Chu; M McShane; E Bovo; Y Ait Mou; A V Zima; P P de Tombe; G L Kartje; J L Martin
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

3.  A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection.

Authors:  Ludovic Gomez; Melanie Paillard; Megan Price; Qun Chen; Geoffrey Teixeira; Sarah Spiegel; Edward J Lesnefsky
Journal:  Basic Res Cardiol       Date:  2011-10-15       Impact factor: 17.165

4.  Adora2b signaling on bone marrow derived cells dampens myocardial ischemia-reperfusion injury.

Authors:  Michael Koeppen; Patrick N Harter; Stephanie Bonney; Megan Bonney; Susan Reithel; Cornelia Zachskorn; Michel Mittelbronn; Tobias Eckle
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

5.  The valosin-containing protein protects the heart against pathological Ca2+ overload by modulating Ca2+ uptake proteins.

Authors:  Shaunrick Stoll; Jing Xi; Ben Ma; Christiana Leimena; Erik J Behringer; Gangjian Qin; Hongyu Qiu
Journal:  Toxicol Sci       Date:  2019-07-31       Impact factor: 4.849

6.  Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia.

Authors:  David A Brown; Sharon L Hale; Christopher P Baines; Carlos L del Rio; Robert L Hamlin; Yukie Yueyama; Anusak Kijtawornrat; Steve T Yeh; Chad R Frasier; Luke M Stewart; Fatiha Moukdar; Saame Raza Shaikh; Kelsey H Fisher-Wellman; P Darrell Neufer; Robert A Kloner
Journal:  J Cardiovasc Pharmacol Ther       Date:  2013-11-28       Impact factor: 2.457

7.  Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.

Authors:  Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  J Hypertens       Date:  2014-01       Impact factor: 4.844

8.  Akt and Erk1/2 activate the ornithine decarboxylase/polyamine system in cardioprotective ischemic preconditioning in rats: the role of mitochondrial permeability transition pores.

Authors:  Hao Zhang; Guo Xue; Weihua Zhang; Lina Wang; Hong Li; Li Zhang; Fanghao Lu; Shuzhi Bai; Yan Lin; Yu Lou; Changqing Xu; Yajun Zhao
Journal:  Mol Cell Biochem       Date:  2014-01-24       Impact factor: 3.396

9.  Cyclosporine A at reperfusion reduces infarct size in pigs.

Authors:  Andreas Skyschally; Rainer Schulz; Gerd Heusch
Journal:  Cardiovasc Drugs Ther       Date:  2010-02       Impact factor: 3.727

10.  Active Wnt signaling in response to cardiac injury.

Authors:  Martinus I F J Oerlemans; Marie-José Goumans; Ben van Middelaar; Hans Clevers; Pieter A Doevendans; Joost P G Sluijter
Journal:  Basic Res Cardiol       Date:  2010-04-07       Impact factor: 17.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.